blog | Aspen Neuroscience

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

IPOs, 2026, Biotech, Biotherapeutics, Aspen Neuroscience, Neuroscience, Bambusa Therapeutics

Aspen Neuroscience and Bambusa Therapeutics Each Target $150 Million IPOs

Eric Friedman

Oct 27, 2026, 1:12:21 PM

Aspen Neuroscience and Bambusa Therapeutics have set terms for their initial public offerings, with ...

Subscribe to our Newsletter

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.

Copyright © 2025